Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CLS Holdings USA's share price for the quarter that ended in Feb. 2024 was C$0.065. CLS Holdings USA's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 137.68 Mil. Therefore, CLS Holdings USA's market cap for the quarter that ended in Feb. 2024 was C$8.95 Mil.
CLS Holdings USA's quarterly market cap
declined
from Aug. 2023 (C$7.98 Mil) to Nov. 2023 (C$3.63 Mil) but then
increased
from Nov. 2023 (C$3.63 Mil) to Feb. 2024 (C$8.95 Mil).
CLS Holdings USA's annual market cap
declined
from May. 2021 (C$24.81 Mil) to May. 2022 (C$13.46 Mil) and
declined
from May. 2022 (C$13.46 Mil) to May. 2023 (C$4.72 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CLS Holdings USA's Enterprise Value for Today is C$21.75 Mil.
CLS Holdings USA Market Cap Historical Data
The historical data trend for CLS Holdings USA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CLS Holdings USA's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CLS Holdings USA's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Market Cap distribution charts can be found below:
* The bar in red indicates where CLS Holdings USA's Market Cap falls into.
CLS Holdings USA Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
CLS Holdings USA's Market Cap for the fiscal year that ended in May. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLS Holdings USA (XCNQ:CLSH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
CLS Holdings USA Market Cap Related Terms
Thank you for viewing the detailed overview of CLS Holdings USA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:CLSH has been successfully added to your 